Lonza to Buy Five U.S. Manufacturing Sites From Merck KGaA
Lonza agreed to buy five U.S. manufacturing sites from Merck KGaA, more than doubling its U.S. footprint. The deal will bring Lonza’s U.S. site count to nine.
Contract drug manufacturer Lonza BX:LO3 will more than double its US footprint after agreeing to buy five manufacturing sites in the country from Merck KGaA XETR:MRK, the Swiss company said on Tuesday.The deal will bring the number of Lonza's US sites to nine, and expand its cell and gene therapy c…